MLXIPL and Hepatic steatosis: Several studies on animal models treated with HFD described the beneficial effect of curcumin in lowering lipid levels and improving hepatic steatosis by interfering with the carbohydrate response element binding protein (ChREBP) and the sterol regulatory element-binding protein 1 (SREBP1-c) pathways in the liver.